UNIL and CHUV are pleased to announce their registration to the CSL Research Acceleration Initiative (CSL RAI).
This program proposed by CSL is to promote innovative biotherapies. Successful applicants will receive from CSL a financial support up to $ 200’000 p.a. for up to 2 years.
To access to CSL RAI, researchers have to submit a non-disclosure abstract between January 2nd and February 27th. Researchers are invited to file this abstract without disclosing their know-how or inventive information about their projects on the following link: https://inova.partneringplace.com/OppPortal/portal/csl/.
Following this first step, selected researchers will be invited to submit a non-disclosure application current March. For this second step, researchers are also invited to file this application without disclosing their know-how or inventive information about their projects.
Full application submission (under a Non-Disclosure Agreement) will open end of March.
For researchers interested a CSL’s webinar, to present this program in more details, is scheduled on January 23rd at 10AM (link to the webinar: Click here to join the meeting) and on January 24th at 4 PM (link to the webinar: Click here to join the meeting).
The webinar will cover the following topics:
For further information, please contact the PACTT at: Alberto.Schena@chuv.ch or Alberto.Schena@unil.ch